Aquatic Capital Management LLC Galapagos Nv Transaction History

Aquatic Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.78 - $32.48 $27,258 - $35,728	-1,100 Reduced 15.94%	5,800 $143,000
Q1 2024 May 15, 2024	BUY	$32.2 - $42.44 $38,640 - $50,928	1,200 Added 21.05%	6,900 $222,000
Q4 2023 Feb 14, 2024	BUY	$31.87 - $40.71 $117,919 - $150,627	3,700 Added 185.0%	5,700 $232,000
Q3 2023 Nov 14, 2023	BUY	$34.17 - $42.98 $61,506 - $77,364	1,800 Added 900.0%	2,000 $69,000
Q2 2023 Aug 14, 2023	BUY	$37.4 - $44.52 $7,480 - $8,904	200 New	200 $8,000
Q3 2022 Nov 14, 2022	BUY	$42.27 - $57.6 $253,620 - $345,600	6,000 Added 272.73%	8,200 $350,000
Q2 2022 Aug 15, 2022	BUY	$52.3 - $71.59 $104,600 - $143,180	2,000 Added 1000.0%	2,200 $123,000
Q1 2022 May 16, 2022	SELL	$51.32 - $68.5 $92,376 - $123,300	-1,800 Reduced 90.0%	200 $12,000
Q4 2021 Feb 14, 2022	BUY	$47.03 - $57.12 $94,060 - $114,240	2,000 New	2,000 $110,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.87B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.